Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Multicenter Double-blind Placebo-Controlled Parallel-Group Randomized Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children

NCT03039621 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT03039621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03039621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Multicenter Double-blind Placebo-Controlled Parallel-Group Randomized Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children
Lead sponsor
Materia Medica Holding
Phase
Phase 4
Overall status
Completed
Start date
October 7, 2016
Completion date
January 9, 2019
Enrollment
287 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory viral infections